Table 1 Key biomarkers and their potential role in osteocytic pro- and anti-apoptotic signaling mechanisms.
From: Osteocyte apoptosis: the roles and key molecular mechanisms in resorption-related bone diseases
Mechanism | Key biomarker | Potential roles |
|---|---|---|
Pro-apoptotic function | ROS | Generate the initial insult on mitochondria; induce either apoptosis or senescence; decrease bone mass and accelerate aging; increase degeneration of the osteocyte LCN24,25,48,72,109 |
BAX | Target the mitochondria; induce rapid release of cyt C; accelerate the caspase cascade49,66 | |
PUMA | Target the mitochondria; induce rapid release of cyt C; accelerate the caspase cascade49 | |
Hcy | Increase the expressions of Nox; induce DNA damage96 | |
HMGB1 | Trigger the generation of pro-inflammatory and pro-osteoclastic factors via positive feedback loop109,110,111,112,114 | |
FADD | Trigger a caspase cascade; induce GCs-induced apoptosis6,118 | |
Sclerostin | Promote osteocyte cells death upon unloading; inhibit bone formation53,107,108 | |
BNIP3 | ||
CCN2 | Promote osteocyte apoptosis upon excess mechanical stress33,69 | |
TNF-α | Stimulate osteocyte apoptosis upon inflammation and cancer92,115,116 | |
Caspase-3 | Regulate osteocyte apoptosis via physical interactions in mechanistic stimulus27,127 | |
CTSK | Breakdown the bone matrix adjacent to the osteocyte; increase the size of the osteocyte lacunae and mineralization decrease vitality of osteocytes23 | |
DMP-1 | Regulate osteocyte formation and phosphate homeostasis; involve in osteocytic apoptosis29,84,154 | |
Pyk2 | Promote GCs-induced osteocytic apoptosis via focal adhesion82 | |
Panx-1 | Promote fatigue-induced osteocytic apoptosis160 | |
Anti-apoptotic function | SOD2 | Suppress aging and loss of bone mass; decrease degeneration of the osteocyte LCN24,61 |
AMPK | ||
NO | Maintain osteocytic vitality by pulsatile fluid flow44,54,100 | |
Cx43 | Involve in gap junction; maintain intercellular communication and mechanical response42,43,158 | |
Beclin-1 | Inhibit the oxidative stress; protect the survival of osteocytes21,22,23,27 | |
LC3 | Inhibit the oxidative stress; protect the survival of osteocytes21,22,23,28 | |
PTH | Reverse the osteocyte apoptosis; promote gap junction-mediated intercellular coupling; stimulate Ca+2 influx133,134,135,137 | |
VEGF | Couple angiogenesis and osteogenesis; preserve osteocytic vitality140,141 | |
β1-integrin | Regulate stretch-induced ERK activation; preserve osteocytic vitality93 | |
Caveolin-1 | Involve in mechanotransduction in osteocytes55 | |
PGE2 | Maintain osteocytic mechanotransduction upon unloading; block GCs-induced apoptosis56 | |
PI3K | Trigger the phosphorylation and inactivate the pro-apoptotic protein; preserve osteocytic vitality82 | |
Sema3A | Inhibit osteoclastic bone resorption and promote bone formation; regulate the survival of mature osteocytes; maintain bone mass in an estrogen-dependent manner77 | |
FGF7 | Increase Cx43 expression; promote gap junction elongate; maintain the survival of osteocytes59 | |
Irisin | ||
CD40 | Block TNF-α or GCs-induced osteocytic apoptosis92 | |
NAC | Alleviate estrogen/androgen deficiency-induced osteocyte apoptosis48 | |
CCL7 | Promote bone formation; maintain osteocytic mechanotransduction; protect from GCs-induced osteocytic apoptosis83 | |
BCL-2 | Suppress osteocytic apoptosis upon unloading/disuse and fatigue66 |